Galvanize Therapeutics
Galvanize Therapeutics, Inc.
Galvanize Therapeutics, Inc. is a commercial-stage medical technology company developing and commercializing pulsed electric field (PEF) energy platforms. The company's technology uses non-thermal electrical pulses to disrupt pathological cells, offering innovative treatments for diseases such as solid tumors, chronic bronchitis, and cardiac arrhythmias.
Products & Team
Aliya® PEF System
The Aliya® system is the company's flagship pulsed electric field energy platform. It has received FDA 510(k) clearance for soft tissue ablation and is also being investigated for its potential to treat solid tumors by stimulating a systemic immune response. An associated component, the INUMI™ Flex Endoscopic Needle, is cleared for use in soft tissue lesions, including those in the lung.
It provides a new, minimally invasive treatment modality for ablating soft tissue and potentially treating solid tumors by disrupting pathological cells without the use of thermal energy, which can damage surrounding healthy tissue.
Addresses the need for effective, minimally invasive treatment options for complex medical conditions such as solid tumors, chronic bronchitis (a primary cause of COPD), and cardiac arrhythmias, which often have limited or highly invasive treatment alternatives.